Haig Aghajanian

Company: Capstan Therapeutics

Job title: Co-founder & Vice President - Research

Seminars:

Leveraging the Learnings from Oncology: Delve into in vivo Generation of CAR-T Cells to Reduce Fibrosis & Restore Cardiac Function 2:00 pm

The promise in vivo generation CAR-T cells hold as a therapeutic platform to treat cardiovascular disease Understanding the use of modified mRNA targeted LNPs to reduce fibrosis and restore cardiac function Evaluating efficacy using a mouse model of heart failureRead more

day: Conference Day 1